Year 2016,
Volume: 1 Issue: 2, 23 - 29, 28.06.2016
Abstract
Hepatit c tedavisindeki başarı direkt etkili oral antivirallerle %90’ları aşmaktadır. Geri ödeme kapsamındaki ilaçlar ülkeden ülkeye değişiklik göstermektedir. Ülkemizde iki farklı kombinasyon (sofosbuvir-ledipasvir ve ombitasvir-paritaprevir- ritonavir- dasabuvir) Haziran 2016’dan itibaren geri ödeme kapsamına alındı. Bununla birlikte bu kombinasyonlarla ilgili düzenlemeler kronik hepatit C tedavisinde yeni şartlar ve sınırlamalar getirdi. Bu derlemede ülkemizdeki hepatit c tedavi şemaları ve geri ödeme şartları eski ve yeni kurallarıyla gözden geçirilmiştir.
Keywords
References
- http://www.resmigazete.gov.tr/default.aspx (Erişim tarihi:23.06.2016).
- Tosun S . Viral hepatitlerin ülkemizdeki değişen epidemiyolojisi. ANKEM Derg 2013;27(Ek 2):128-134.
- Chen SL. The Natural History of Hepatitis C Virus (HCV) Infection. International Journal of Medical Sciences Int J Med Sci 2006;3(2):47-52.
- Sarasin-Filipowicz M. Interferon therapy of hepatitis C: molecular insights
- into success and failure. Swiss Med Wkly. 2010 Jan 9;140(1-2):3-11.
- American Association for the study of liver diseases (AASLD) and Infectious Diseases Society of America (IDSA). HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C http://www.hcvguidelines.org (Erişim tarihi: 22.06.2016).
- Zhu Y, Chen S. Antiviral treatment of hepatitis C virus infection and factors
- affecting efficacy. World J Gastroenterol. 2013 Dec 21;19(47):8963-73.
- Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014 May 15;370(20):1889-98.
- Feld JJ, Kowdley KV, Coakley E, et al. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014; 370: 1594–603.
- Holmes JA, Thompson AJ. Interferon-free combination therapies fort he treatment of hepatitis C: current insights. Hepat Med. 2015 Nov 2;7:51-70.
Year 2016,
Volume: 1 Issue: 2, 23 - 29, 28.06.2016
Abstract
References
- http://www.resmigazete.gov.tr/default.aspx (Erişim tarihi:23.06.2016).
- Tosun S . Viral hepatitlerin ülkemizdeki değişen epidemiyolojisi. ANKEM Derg 2013;27(Ek 2):128-134.
- Chen SL. The Natural History of Hepatitis C Virus (HCV) Infection. International Journal of Medical Sciences Int J Med Sci 2006;3(2):47-52.
- Sarasin-Filipowicz M. Interferon therapy of hepatitis C: molecular insights
- into success and failure. Swiss Med Wkly. 2010 Jan 9;140(1-2):3-11.
- American Association for the study of liver diseases (AASLD) and Infectious Diseases Society of America (IDSA). HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C http://www.hcvguidelines.org (Erişim tarihi: 22.06.2016).
- Zhu Y, Chen S. Antiviral treatment of hepatitis C virus infection and factors
- affecting efficacy. World J Gastroenterol. 2013 Dec 21;19(47):8963-73.
- Afdhal N, Zeuzem S, Kwo P, et al. Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection. N Engl J Med. 2014 May 15;370(20):1889-98.
- Feld JJ, Kowdley KV, Coakley E, et al. Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin. N Engl J Med 2014; 370: 1594–603.
- Holmes JA, Thompson AJ. Interferon-free combination therapies fort he treatment of hepatitis C: current insights. Hepat Med. 2015 Nov 2;7:51-70.
There are 11 citations in total.
Details
| Journal Section | Review article |
|---|---|
| Authors | |
| Publication Date | June 28, 2016 |
| Submission Date | June 24, 2016 |
| Published in Issue | Year 2016 Volume: 1 Issue: 2 |
Online Türk Sağlık Bilimleri Dergisi [Online Turkish Journal of Health Sciences (OTJHS)] is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an open-access journal distributed under the terms of the Creative Commons Attribution License (CC BY-NC 4.0). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Click here to get help about article submission processes and "Copyright Transfer Form".